Almenoff June Sherie

Average Profitability
12.25%
Insider Buys Quantity
4
Insider Buys Sum
$37,699.75
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Almenoff June Sherie

According to the SEC Form 4 filings, Almenoff June Sherie, being in a position of

  1. director at Avalo Therapeutics, Inc.,
    оver the last 12 months, has bought 1000 shares for $12,750, and sold 0 shares,
    over all time since 2024-11-12, has bought 1000 shares for $12,750, and sold 0 shares.

The largest purchase of all time was on 2018-03-15 and amounted to 5700 shares of Brainstorm Cell Therapeutics Inc. for $19,950.

Biography of Almenoff June Sherie

No biography is available at this moment.

2024-11-13PurchaseAvalo Therapeutics, Inc.
AVTX
director
500
0.4267%
$13.00$6,500-26.49%
2024-11-12PurchaseAvalo Therapeutics, Inc.
AVTX
director
500
0.4103%
$12.50$6,250-22.68%
2019-01-04PurchaseBrainstorm Cell Therapeutics Inc.
BCLI
director
1,475
0.0071%
$3.39$5,000+15.43%
2018-03-15PurchaseBrainstorm Cell Therapeutics Inc.
BCLI
director
5,700
0.0306%
$3.50$19,950+9.06%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.